JM
Publicaties op Oncologisch.com
Surgical Outcomes With Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC.
Totale overleving with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer.
Perioperatieve nivolumab bij resectabel longcarcinoom: CheckMate 77T OS update
Perioperatieve durvalumab bij resectabel NSCLC: AEGEAN fase III
Neoadjuvant nivolumab plus chemotherapie bij resectabel longcarcinoom: CheckMate 816 fase III
Neoadjuvante systeemtherapie bij melanoom: internationale consensusaanbevelingen